Lipocine Inc (LPCN)
5.32
+0.49
(+10.14%)
USD |
NASDAQ |
Apr 17, 16:00
5.32
0.00 (0.00%)
After-Hours: 20:00
Lipocine Cash from Investing (Quarterly): 2.727M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.727M |
| September 30, 2023 | 1.243M |
| June 30, 2023 | 3.560M |
| March 31, 2023 | 5.555M |
| December 31, 2022 | 2.596M |
| September 30, 2022 | 0.6139M |
| June 30, 2022 | 3.788M |
| March 31, 2022 | 7.295M |
| December 31, 2021 | -9.723M |
| September 30, 2021 | 1.368M |
| June 30, 2021 | -1.432M |
| March 31, 2021 | -33.99M |
| December 31, 2020 | 5.408M |
| September 30, 2020 | -1.398M |
| June 30, 2020 | -4.019M |
| March 31, 2020 | 3.902M |
| December 31, 2019 | 0.5574M |
| September 30, 2019 | 5.971M |
| June 30, 2019 | -1.448M |
| March 31, 2019 | -2.082M |
| December 31, 2018 | 4.946M |
| September 30, 2018 | 6.470M |
| June 30, 2018 | 0.7809M |
| March 31, 2018 | -0.9032M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.809M |
| September 30, 2017 | -5.179M |
| June 30, 2017 | 8.686M |
| March 31, 2017 | 1.428M |
| December 31, 2016 | 2.830M |
| September 30, 2016 | -3.617M |
| June 30, 2016 | 3.434M |
| March 31, 2016 | 0.5821M |
| December 31, 2015 | -1.006M |
| September 30, 2015 | -8.871M |
| June 30, 2015 | -15.13M |
| March 31, 2015 | -0.0132M |
| December 31, 2014 | -0.0383M |
| September 30, 2014 | -0.0194M |
| June 30, 2014 | 0.0212M |
| March 31, 2014 | -0.0019M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.0012M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.0124M |
| September 30, 2012 | -0.0124M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-33.99M
Minimum
Mar 2021
7.295M
Maximum
Mar 2022
-0.391M
Average
1.368M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | -112.70M |
| NeuroBo Pharmaceuticals Inc | -0.009M |
| Eliem Therapeutics Inc | 36.75M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.022M |
| Cash from Financing (Quarterly) | -0.0053M |
| Free Cash Flow | -11.88M |
| Free Cash Flow Per Share (Quarterly) | -0.3821 |
| Free Cash Flow to Equity (Quarterly) | -2.032M |
| Free Cash Flow to Firm (Quarterly) | -2.032M |
| Free Cash Flow Yield | -42.43% |